Sign the Pancreatic Cancer Research Program Dear Colleague
Dear [Decision Maker],
As your constituent, and someone who is committed to improving outcomes for pancreatic cancer patients and their families, I urge you to sign the Whitehouse-Crapo Dear Colleague letter to the Senate Appropriations Subcommittee on Defense. Your support for the Pancreatic Cancer Research Program at the Department of Defense (DoD) will lead to advancements in research for the world's toughest cancer.
In FY20, Congress took a crucial step and created a dedicated pancreatic cancer research program at the DoD. I applaud Congress's bipartisan effort. This is a critical research investment for a disease with a five-year survival rate of only 10% in the U.S., and 65% of patients die within their first year of diagnosis. There is an urgent need for more research efforts to change these statistics for patients.
Research shows that within a cohort of U.S. veterans, there is direct evidence for increased risk of death from pancreatic cancer. Veterans often have known risk factors for pancreatic cancer, including environmental exposure, other medical conditions such as diabetes, and lifestyles factors such as smoking and obesity. I urge you to sign the Dear Colleague letter spearheaded by Senators Sheldon Whitehouse (D-RI) and Mike Crapo (R-ID). The letter to the Senate Appropriations Defense Subcommittee requests continued and adequate funding for the dedicated pancreatic cancer research program. While the number of researchers focused on pancreatic cancer is growing, thanks in part to you and your colleagues, we must make sure they have the adequate resources necessary to accelerate progress.
I ask that you sign this letter by Tuesday, March 24, to ensure its consideration during the FY21 appropriations process. Please contact Becca Flikier (Becca_Flikier@whitehouse.senate.gov) in Sen. Whitehouse's office or Kellie McConnell (Kellie_McConnell@crapo.senate.gov) in Sen. Crapo's office to sign on in support of all those impacted by this devastating disease. I stand with the Pancreatic Cancer Action Network (PanCAN) and the patients, caregivers, families and researchers across the country in asking for your support and commitment to greatly improving patient outcomes.
[Your Name] [Your Address] [City, State ZIP] [Your Email]